This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center
Menu
Book
keyboard_arrow_right

DIGITAL - SEP 28 - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search

DIGITAL - SEP 28 - EST/EDT (Eastern Daylight, GMT-4)

search
11:00am - 11:05am5 mins
Opening Remarks (LIVE)
    11:05am - 11:35am30 mins
    KEYNOTE: Biomanufacturing Challenges and Opportunities in Cell Therapies for Immuno-oncology
    • Susan Sharfstein, PhD - Professor of Nanobioscience, College of Nanoscale Science and Engineering, SUNY Polytechnic Institute
    11:40am - 12:10pm30 mins
    KEYNOTE: A Collaborative Ecosystem To Accelerate the Commercial Manufacturing of Novel Vaccines and Other Therapeutics
    • Nandu Deorkar - Vice President, Avantor
    12:10pm - 12:30pm20 mins
    Networking Break
      12:30pm - 1:00pm30 mins
      Bioprocess International
      Presentation by GIBCO Thermo
        12:30pm - 1:00pm30 mins
        Cell & Gene Therapy Manufacturing & Commercialization
        Midstream Unit Operations: Unsung Heroes in AAV Process Development
        • Ratish Krishnan - Associate Director - Cell & Gene Therapy BioProcessing, MilliporeSigma
        1:05pm - 1:35pm30 mins
        Bioprocess International
        Cell Line/Cell Culture (NEW CONTENT - PRE-RECORDED)
          1:05pm - 1:35pm30 mins
          Cell & Gene Therapy Manufacturing & Commercialization
          Analytics Linked to Process and Critical Quality Attributes for Gene Therapies
          • Lyndi Rice - Head of QC Viral Vector Analytical, BioMarin
          1:40pm - 2:10pm30 mins
          Bioprocess International
          Presentation by PRECISION NANOSYSTEMS
            1:40pm - 2:10pm30 mins
            Cell & Gene Therapy Manufacturing & Commercialization
            Acceleration of AAV manufacturing process development by using fast USP and DSP HPLC analytics
            • Ales Strancar, PhD - Managing Director, BIA Separations
            2:15pm - 2:45pm30 mins
            Bioprocess International
            BPI Panel Discussion: Workflows & Technologies to Accelerate Early Stage Development
              2:15pm - 2:45pm30 mins
              Cell & Gene Therapy Manufacturing & Commercialization
              Speaker Q&A (LIVE)
              • Ratish Krishnan - Associate Director - Cell & Gene Therapy BioProcessing, MilliporeSigma
              • Lyndi Rice - Head of QC Viral Vector Analytical, BioMarin
              • Ales Strancar, PhD - Managing Director, BIA Separations
              CONFERENCE DAY THREE
              NextDIGITAL - SEP 29
              Filter
              Streams
              Formats
              Choose Day